GTS Securities’s New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF LRND Stock Holding History
Bought
Maintained
Sold
Other funds holding LRND
NYLIM
SG
GTS Securities's LRND Position: Q2 2026 in Review
GTS Securities sold out of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) in Q2 2026, closing a stake of 22,354 shares — an estimated $831K sold.
GTS Securities first reported a position in LRND in Q4 2023 and held it in 9 quarters. The position peaked at $831K in Q1 2026. 6 funds tracked by Wall St. Rank hold LRND as of Q2 2026.
- GTS Securities reported no remaining New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF position as of Q2 2026 after selling out during the quarter.
- GTS Securities sold 22,354 New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF shares in Q2 2026, an estimated $831K.
- GTS Securities first reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in Q4 2023 and held it in 9 quarters.
- GTS Securities's New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF position peaked at $831K in Q1 2026.
- 6 funds tracked by Wall St. Rank held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF as of Q2 2026.
Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.